The National Cancer Society Malaysia has made an urgent appeal for the government to establish a coordinated national screening programme targeting cardio-renal-metabolic diseases, warning that the interconnected conditions of heart disease, kidney problems and diabetes are spreading rapidly through the population with alarming consequences for public health.
According to NCSM, the scale of the problem is substantial and growing. Research data shows that approximately nine out of every ten Malaysians carry two or more risk factors for these interconnected conditions, suggesting that a significant portion of the population faces heightened vulnerability to serious health complications. The organisation emphasises that these diseases do not develop in isolation; instead, they share common underlying causes and actually accelerate each other's progression, creating a compounding health crisis that demands urgent systemic intervention.
The urgency of NCSM's call stems from findings generated through the Saring@Komuniti Project, a collaborative initiative conducted with pharmaceutical company Boehringer Ingelheim and support from the Ministry of Health. This screening programme examined 5,000 individuals from economically disadvantaged areas across the Klang Valley region, revealing a troubling concentration of interconnected cardiovascular, kidney and metabolic diseases among vulnerable populations. The project's results underscore the inadequacy of current healthcare delivery models, which NCSM argues operate in silos rather than addressing the systemic nature of these conditions.
The screening data paints a sobering picture of Malaysia's metabolic health crisis. Nearly half of those examined, specifically 41.3 per cent, were classified as obese, while a further 28.8 per cent were overweight, meaning more than seven out of ten participants carried excess weight. Even more concerning, 34.5 per cent showed evidence of pre-diabetes and 35.1 per cent had already developed diabetes, indicating a massive hidden burden of blood sugar dysregulation that extends far beyond those currently receiving treatment. The staggering finding that 97.8 per cent of participants had at least one cardio-renal-metabolic risk factor suggests these diseases are nearly universal problems affecting essentially the entire screened population.
The trajectory of chronic kidney disease in Malaysia demonstrates how these conditions have been spiralling out of control. Between 2011 and 2019, the prevalence of chronic kidney disease increased sharply from 9.1 per cent to 15.5 per cent of the population, representing a seventy per cent increase in just eight years. Even more dramatically, the number of Malaysians requiring dialysis treatment has more than tripled over the past two decades, straining healthcare infrastructure and imposing enormous financial and personal costs on affected families. These statistics illustrate the mounting pressure on the healthcare system and signal that without intervention, the burden will continue escalating exponentially.
NCSM's policy recommendations centre on two fundamental shifts in how Malaysia approaches these diseases. First, the organisation advocates expanding integrated co-screening programmes that screen for multiple conditions simultaneously, allowing healthcare workers to identify patients with overlapping risks earlier in their disease trajectory when intervention is more effective. Second, NCSM stresses the necessity of strengthening the entire continuum of care, ensuring that individuals identified through screening actually progress through diagnosis, treatment initiation and sustained long-term management rather than falling through gaps in the fragmented system.
The current fragmentation of Malaysia's healthcare approach represents a critical vulnerability. Healthcare providers typically address cardiovascular disease, kidney disease and diabetes as separate entities, missing crucial opportunities to recognise that a patient presenting with one condition likely carries risks for the others. This siloed approach means that many individuals with multiple overlapping conditions receive incomplete assessment and treatment. Additionally, inconsistent referral pathways between primary care and specialist services, combined with poor follow-up mechanisms, often result in patients diagnosed through screening falling out of care before they receive appropriate treatment, negating the value of early detection.
To remedy these systemic deficiencies, NCSM's policy briefs recommend several concrete actions. These include scaling up cardio-renal-metabolic co-screening programmes across all states, embedding standardised risk assessments into routine health check-ups provided through government clinics and workplaces, and establishing stronger referral mechanisms with mandatory follow-up systems to track patients identified as having abnormalities. Such measures would require coordination between the Ministry of Health, private healthcare providers and employers to create a genuinely integrated system rather than the fragmented collection of programmes currently in place.
Dr Murallitharan Munisamy, Managing Director of NCSM, articulated the fundamental challenge facing Malaysia's health system. He emphasised that the country stands at a crossroads, with the opportunity to transition from managing diseases as isolated problems to treating cardiovascular, kidney and metabolic health as an interconnected system. He stressed that early detection alone provides insufficient benefit without coordinated follow-up and sustained long-term care. This observation reflects growing international evidence that screening programmes without robust implementation systems often fail to improve health outcomes and may even waste resources.
Boehringer Ingelheim, the biopharmaceutical company that partnered with NCSM on the Saring@Komuniti Project, has articulated the scientific rationale underlying these calls for integration. The company's representatives note that cardiovascular, kidney and metabolic conditions are fundamentally interconnected, sharing common risk factors such as obesity, hypertension and poor glycaemic control while simultaneously amplifying each other's damaging effects. This biological reality means that effective treatment must address the entire constellation of interconnected risks rather than focusing narrowly on individual diseases.
The timing of NCSM's policy recommendations is significant given Malaysia's ongoing struggle with rising chronic disease rates. Unlike acute infectious diseases that governments can combat through vaccination campaigns or quarantine measures, the cardio-renal-metabolic disease epidemic develops silently within populations over years and decades. By the time individuals present with symptoms, substantial irreversible damage has often occurred. National screening strategies enable earlier identification of asymptomatic individuals at high risk, theoretically allowing preventive interventions before disease becomes advanced and expensive to manage.
For Malaysian policymakers, the challenge extends beyond acknowledging the problem. Implementing a true integrated screening and care system requires substantial investment in training healthcare workers in multi-disease assessment, establishing reliable information systems to track patient progression through the care continuum, and fundamentally restructuring how primary care clinics operate. It also requires engagement with private healthcare providers to ensure coordination across the entire healthcare system rather than creating parallel systems that serve different populations. The alternative, NCSM argues, is continued escalation of chronic disease burden with mounting costs to patients and the healthcare system alike.
